2010 White Paper on Recent Issues in Regulated Bioanalysis & Global Harmonization of Bioanalytical Guidance-Reference-Cited by-同舟云学术

2010 White Paper on Recent Issues in Regulated Bioanalysis & Global Harmonization of Bioanalytical Guidance

Published:2010-12 Issue:12 Volume:2 Page:1945-1960
ISSN:1757-6180
Container-title:Bioanalysis
language:en
Short-container-title:Bioanalysis

Author:

Savoie Natasha¹,Garofolo Fabio¹,van Amsterdam Peter²,Bansal Surendra³,Beaver Chris⁴,Bedford Patrick⁵,Booth Brian P⁶,Evans Christopher⁷,Jemal Mohammed⁸,Lefebvre Marc¹,Lopes de Silva Arthur Leonardo⁹,Lowes Steve¹⁰,Marini Joseph C¹¹,Massé Robert¹²,Mawer Louise¹³,Ormsby Eric⁵,Rocci Jr Mario L¹⁴,Viswanathan CT⁶,Wakelin-Smith Jason¹³,Welink Jan¹⁵,White Joleen T⁸,Woolf Eric¹⁶

Affiliation:

1. Algorithme Pharma Inc., 575 Armand-Frappier Blvd, Laval (Montreal) Quebec, H7V 4B3, Canada.

2. Abbott Healthcare Products BV, Weesp, Netherlands

3. Hoffmann-La Roche, Nutley, NJ, USA

4. MDS Pharma Services, QC, Canada

5. Health Canada TPD, Ottawa, ON, Canada

6. Food and Drug Administration, CDER, Silver Spring, MD, USA

7. GlaxoSmithKline, King of Prussia, PA, USA

8. Bristol-Myers Squibb, Princeton, NJ, USA

9. ANVISA, Brasilia, Brazil

10. Advion BioServices Inc., Ithaca, NY, USA

11. Centocor R&D, Inc.Johnson & Johnson, Radnor, PA, USA

12. Anapharm/PharmaNet, Quebec City, QC, Canada

13. Medicines and Healthcare products Regulatory Agency (MHRA), London, UK

14. ICON Development Solutions, Whitesboro, NY, USA

15. Medicines Evaluation Board, The Hague, The Netherlands

16. Merck Research Laboratories, West Point, PA, USA

Abstract

The 4th Calibration and Validation Group Workshop on Recent Issues in Regulated Bioanalysis, a 2-day full immersion workshop, was organized by the Calibration and Validation Group. Contract research organizations, pharmaceutical companies and regulatory agencies came together to discuss several ‘hot’ topics concerning bioanalytical issues and regulatory challenges and to reach a consensus among panelists and attendees on many points regarding method validation of small and large molecules.

Publisher

Future Science Ltd

Subject

Medical Laboratory Technology,Clinical Biochemistry,General Pharmacology, Toxicology and Pharmaceutics,General Medicine,Analytical Chemistry

Link

http://www.future-science.com/doi/pdf/10.4155/bio.10.164

Reference34 articles.

1. Society Spotlight: Spotlight on the Calibration and Validation Group

2. The 2nd Calibration and Validation Group Workshop on recent issues in Good Laboratory Practice bioanalysis

3. 2009 White Paper on Recent Issues in Regulated Bioanalysis from The 3rd Calibration and Validation Group Workshop

4. EMA.Draft Guideline on the Validation of Bioanalytical Methods.EMA, Committee for Proprietary Medicinal Products (CPMP), London, UK (2009).

5. ANVISA. Resolution RE no. 899, 23 May 2003. Brazilian Sanitary Surveillance Agency, Brazil (2003).

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2023 White Paper on Recent Issues in Bioanalysis: Deuterated Drugs; LNP; Tumor/FFPE Biopsy; Targeted Proteomics; Small Molecule Covalent Inhibitors; Chiral Bioanalysis; Remote Regulatory Assessments; Sample Reconciliation/Chain of Custody (PART 1A – Recommendations on Mass Spectrometry, Chromatography, Sample Preparation Latest Developments, Challenges, and Solutions and BMV/Regulated Bioanalysis PART 1B - Regulatory Agencies' Inputs on Regulated Bioanalysis/BMV, Biomarkers/IVD/CDx/BAV, Immunogenicity, Gene & Cell Therapy and Vaccine);Bioanalysis;2024-05-02

2. 2023 White Paper on Recent Issues in Bioanalysis: EU IVDR 2017/746 Implementation/Impact, IVD/CDx/CLIA Approved Assays, High Dimensional Cytometry, Multiplexing Technologies, LBA Tissue Analysis, Vaccine Study Endpoints, Cell-Based Assays for Biomarkers, Cell Therapy and Vaccines ( PART 2 – Recommendations on Development & Validation of Biomarkers, IVD, CDx, Cell-Based, Flow Cytometry, Ligand-Binding and Enzyme Assays; Advanced Critical Reagents Strategies);Bioanalysis;2024-04-17

3. 2023 White Paper on Recent Issues in Bioanalysis: ISR for ADA Assays, the Rise of dPCR vs qPCR, International Reference Standards for Vaccine Assays, Anti-AAV TAb Post-Dose Assessment, NanoString Validation, ELISpot as Gold Standard (Part 3 – Recommendations on Gene Therapy, Cell Therapy, Vaccines Immunogenicity & Technologies; Biotherapeutics Immunogenicity & Risk Assessment; ADA/NAb Assay/Reporting Harmonization);Bioanalysis;2024-02-22

4. 2022 White Paper on Recent Issues in Bioanalysis: Enzyme Assay Validation, BAV for Primary End Points, Vaccine Functional Assays, Cytometry in Tissue, LBA in Rare Matrices, Complex NAb Assays, Spectral Cytometry, Endogenous Analytes, Extracellular Vesicles Part 2 – Recommendations on Biomarkers/CDx, Flow Cytometry, Ligand-Binding Assays Development & Validation; Emerging Technologies; Critical Reagents Deep Characterization;Bioanalysis;2023-08

5. 2022 White Paper on Recent Issues in Bioanalysis: ICH M10 BMV Guideline & Global Harmonization; Hybrid Assays; Oligonucleotides & ADC; Non-Liquid & Rare Matrices; Regulatory Inputs (Part 1A – Recommendations on Mass Spectrometry, Chromatography and Sample Preparation, Novel Technologies, Novel Modalities, and Novel Challenges, ICH M10 BMV Guideline & Global Harmonization Part 1B - Regulatory Agencies' Inputs on Regulated Bioanalysis/BMV, Biomarkers/CDx/BAV, Immunogenicity, Gene & Cell Therapy and Vaccine);Bioanalysis;2023-08